LAUSR

Suppression of ribosomal protein RPS6KB1 by Nexrutine increases sensitivity of prostate tumors to radiation.

Sign Up to like & get
recommendations!
0 Published in 2018 at "Cancer letters"

DOI: 10.1016/j.canlet.2018.07.009

Abstract: Radiation therapy (XRT) is a standard treatment for prostate cancer (PCa). Although dose escalation increases local control, toxicity hampers further escalation. Broader improvement will be possible by the addition of adjuvant therapies, which can synergize… read more here.

Keywords: sensitivity; pca; ribosomal protein; suppression ribosomal ... See more keywords